Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.63 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | RAD52 | P43351 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.49 |
| ▸ | DGKA | P23743 | 1/20 | 0.48 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.43 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.43 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9766347 | 1.00 | NAAA (0.63) | NAAAGPR84FFAR1NPSR1RAD52 | |
| SCHEMBL16163271 | 1.00 | NAAA (0.63) | NAAAGPR84FFAR1NPSR1RAD52 | |
| SCHEMBL9766310 | 1.00 | NAAA (0.63) | NAAAGPR84FFAR1NPSR1RAD52 | |
| SCHEMBL17841689 | 1.00 | NAAA (0.63) | NAAAGPR84FFAR1NPSR1RAD52 | |
| SCHEMBL28111455 | 1.00 | NAAA (0.63) | NAAAGPR84FFAR1NPSR1RAD52 | |
| SCHEMBL6372965 | 1.00 | NAAA (0.63) | NAAAGPR84FFAR1NPSR1RAD52 | |
| SCHEMBL15234476 | 0.98 | NAAA (0.60) | NAAAGPR84FFAR1NPSR1RAD52 | |
| SCHEMBL18915407 | 0.93 | NAAA (0.52) | NAAAGPR84FFAR1NPSR1RAD52 | |
| SCHEMBL6368140 | 0.93 | NAAA (0.52) | NAAAGPR84FFAR1NPSR1RAD52 | |
| SCHEMBL942675 | 0.93 | NAAA (0.52) | NAAAGPR84FFAR1NPSR1RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130004439-A1 | Lipo-Phosphated or Lipo-Sulphated Compound, Compositions Comprising It and Topical Uses Thereof | SEDERMA, S.A.S. (FR) | 2013-01-03 | — | — | US | disclosed |
| US-20130004439-A1 | Lipo-Phosphated or Lipo-Sulphated Compound, Compositions Comprising It and Topical Uses Thereof | SEDERMA, S.A.S. (FR) | 2013-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130004439-A1 | Lipo-Phosphated or Lipo-Sulphated Compound, Compositions Comprising It and Topical Uses Thereof | LOXL3, CUTA, LOXL4 | NAAA 625/4885GPR84 618/4885FFAR1 85/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.